Profile data is unavailable for this security.
About the company
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
- Revenue in USD (TTM)1.32bn
- Net income in USD118.75m
- Incorporated2020
- Employees3.90k
- LocationConmed Corp11311 Concept BoulevardLARGO 33773United StatesUSA
- Phone+1 (727) 214-2974
- Fax+1 (302) 655-5049
- Websitehttps://www.conmed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neogen Corp | 906.00m | -485.26m | 1.17bn | 2.92k | -- | 0.4397 | -- | 1.29 | -2.24 | -2.24 | 4.18 | 12.26 | 0.2102 | 2.39 | 5.43 | 310,591.70 | -11.26 | 1.38 | -11.67 | 1.44 | 48.79 | 48.23 | -53.56 | 4.31 | 2.45 | 0.88 | 0.2513 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
| Adapthealth Corp | 3.25bn | 78.62m | 1.24bn | 10.50k | 15.95 | 0.7936 | 2.65 | 0.3833 | 0.5779 | 0.5779 | 23.91 | 11.62 | 0.7262 | 20.92 | 7.66 | 309,177.20 | 2.01 | -2.81 | 2.29 | -3.17 | 23.35 | 19.63 | 2.77 | -4.19 | 1.07 | 2.24 | 0.5596 | -- | 1.90 | 43.84 | 112.19 | -- | 70.36 | -- |
| Establishment Labs Holdings Inc | 170.24m | -89.10m | 1.30bn | 1.03k | -- | 33.66 | -- | 7.63 | -3.10 | -3.10 | 5.94 | 1.33 | 0.536 | 0.7032 | 2.98 | 167,225.00 | -28.06 | -31.53 | -34.39 | -39.32 | 66.35 | 65.46 | -52.34 | -45.09 | 2.05 | -2.41 | 0.8511 | -- | 0.5292 | 13.14 | -7.76 | -- | 17.33 | -- |
| Evolent Health Inc | 2.40bn | -140.48m | 1.31bn | 4.50k | -- | 1.38 | -- | 0.5472 | -1.22 | -1.22 | 20.86 | 9.74 | 0.9057 | -- | 5.59 | 533,052.70 | -4.11 | -5.93 | -5.59 | -8.00 | 15.25 | 21.07 | -4.54 | -7.16 | -- | 0.276 | 0.4206 | -- | 30.09 | 30.04 | 34.31 | -- | -6.87 | -- |
| Artivion Inc | 390.08m | -21.36m | 1.34bn | 1.60k | -- | 4.57 | 572.89 | 3.44 | -0.5102 | -0.5102 | 9.31 | 6.89 | 0.4953 | 1.72 | 4.81 | 243,802.50 | -2.72 | -2.47 | -2.90 | -2.66 | 63.94 | 65.02 | -5.49 | -5.89 | 3.95 | 0.8589 | 0.5197 | -- | 9.75 | 7.06 | 56.37 | -- | 6.75 | -- |
| Omnicell Inc | 1.14bn | 21.18m | 1.34bn | 3.62k | 63.46 | 1.07 | 12.26 | 1.18 | 0.4521 | 0.4521 | 24.39 | 26.84 | 0.5122 | 6.62 | 4.54 | 309,470.00 | 0.9553 | 1.07 | 1.24 | 1.40 | 43.24 | 45.58 | 1.87 | 1.93 | 1.23 | -- | 0.2135 | 0.00 | -3.04 | 4.39 | 161.51 | -27.21 | -3.06 | -- |
| AtriCure Inc | 480.08m | -38.18m | 1.52bn | 1.30k | -- | 3.34 | -- | 3.17 | -0.8101 | -0.8101 | 10.19 | 9.19 | 0.8115 | 1.65 | 8.09 | 369,289.20 | -6.45 | -3.84 | -7.20 | -4.25 | 74.76 | 74.53 | -7.95 | -7.13 | 2.88 | -21.61 | 0.1335 | -- | 16.55 | 15.05 | -46.85 | -- | 14.00 | -- |
| 10X Genomics Inc | 624.66m | -157.04m | 1.58bn | 1.31k | -- | 2.23 | -- | 2.52 | -1.30 | -1.30 | 5.15 | 5.74 | 0.6841 | 2.50 | 8.68 | 478,301.70 | -17.20 | -25.61 | -19.51 | -29.19 | 68.36 | 74.03 | -25.14 | -47.52 | 4.68 | -- | 0.00 | -- | -1.28 | 19.96 | 28.41 | -- | -20.72 | -- |
| Conmed Corp | 1.32bn | 118.75m | 1.59bn | 3.90k | 13.44 | 1.62 | 8.31 | 1.21 | 3.82 | 3.82 | 42.27 | 31.61 | 0.5713 | 1.71 | 5.69 | 337,435.40 | 5.16 | 1.85 | 5.89 | 2.11 | 56.14 | 55.15 | 9.02 | 3.44 | 1.00 | 5.04 | 0.4771 | 63.56 | 5.00 | 6.47 | 105.44 | 35.85 | -8.20 | 0.00 |
| Alphatec Holdings Inc | 642.27m | -165.54m | 1.61bn | 867.00 | -- | -- | -- | 2.50 | -1.15 | -1.15 | 4.45 | -0.4243 | 0.8234 | 1.23 | 7.01 | 740,790.10 | -21.22 | -27.43 | -26.85 | -34.69 | 68.96 | 66.99 | -25.77 | -39.40 | 1.67 | -11.66 | 1.13 | -- | 26.81 | 40.07 | 13.14 | -- | 48.19 | -- |
| Premier Inc | 1.10bn | 104.27m | 1.74bn | 2.90k | 20.85 | 1.14 | 7.42 | 1.58 | 1.01 | 0.5705 | 11.31 | 18.50 | 0.3419 | -- | 2.51 | 379,330.30 | 3.58 | 7.08 | 4.78 | 8.95 | 70.96 | 61.29 | 10.48 | 16.05 | -- | -- | 0.38 | 27.32 | 0.7684 | 2.03 | -31.70 | -11.93 | -2.76 | -- |
| UFP Technologies Inc | 547.56m | 63.47m | 1.87bn | 4.15k | 29.76 | 5.18 | 23.44 | 3.41 | 8.15 | 8.15 | 70.31 | 46.80 | 1.04 | 4.75 | 7.06 | 132,069.50 | 12.09 | 10.12 | 13.83 | 11.53 | 28.99 | 27.07 | 11.59 | 10.64 | 1.45 | 8.86 | 0.3364 | 0.00 | 26.08 | 20.52 | 31.29 | 24.46 | 10.82 | -- |
| LeMaitre Vascular Inc | 226.26m | 45.16m | 1.89bn | 651.00 | 42.34 | 5.44 | 34.38 | 8.36 | 1.98 | 1.98 | 9.90 | 15.38 | 0.4973 | 1.12 | 6.92 | 347,551.50 | 9.93 | 9.09 | 10.52 | 9.89 | 68.80 | 66.24 | 19.96 | 16.64 | 13.83 | -- | 0.3258 | 38.38 | 13.63 | 13.40 | 46.28 | 19.68 | 13.11 | 13.79 |
| Enovis Corp | 2.15bn | -811.94m | 1.94bn | 7.37k | -- | 0.7425 | -- | 0.9041 | -14.52 | -14.47 | 38.53 | 45.83 | 0.4154 | 1.63 | 5.27 | 291,867.90 | -15.67 | -3.14 | -17.40 | -3.56 | 55.68 | 52.01 | -37.72 | -9.77 | 1.32 | 0.9747 | 0.3462 | -- | 23.46 | -8.73 | -1,423.10 | -- | 7.58 | -- |
| Novocure Ltd | 621.71m | -164.19m | 1.96bn | 1.49k | -- | 5.42 | -- | 3.16 | -1.51 | -1.51 | 5.72 | 3.25 | 0.5246 | 3.47 | 8.31 | 417,816.50 | -13.85 | -9.61 | -22.39 | -11.84 | 77.16 | 77.57 | -26.41 | -19.32 | 1.41 | -- | 0.6446 | -- | 18.82 | 11.49 | 18.55 | -- | 32.52 | -- |
| Quidelortho Corp | 2.76bn | -358.70m | 2.05bn | 6.60k | -- | 0.6833 | 23.61 | 0.7421 | -5.33 | -5.33 | 41.05 | 44.40 | 0.42 | 2.56 | 8.74 | 418,893.90 | -5.45 | 0.0044 | -6.33 | 0.005 | 46.94 | 59.13 | -12.97 | 0.009 | 0.6637 | 0.535 | 0.4548 | 0.00 | -7.17 | 39.07 | -20,216.83 | -- | 48.27 | -- |
Data as of Jul 11 2025. Currency figures normalised to Conmed Corp's reporting currency: US Dollar USD
63.22%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2025 | 4.56m | 14.76% |
| The Vanguard Group, Inc.as of 31 Mar 2025 | 3.43m | 11.11% |
| EARNEST Partners LLCas of 31 Mar 2025 | 2.80m | 9.06% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2025 | 1.67m | 5.41% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 1.30m | 4.21% |
| Managed Account Advisors LLCas of 31 Mar 2025 | 1.28m | 4.14% |
| Westwood Management Corp. (Texas)as of 31 Mar 2025 | 1.24m | 4.00% |
| Fuller & Thaler Asset Management, Inc.as of 31 Mar 2025 | 1.17m | 3.80% |
| Champlain Investment Partners LLCas of 31 Mar 2025 | 1.04m | 3.37% |
| Silvercrest Asset Management Group LLCas of 31 Mar 2025 | 1.04m | 3.35% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
